141.20
0.00
(0.00%)
At close: January 8 at 10:43:26 AM GMT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 17 | 6 | 21 | 21 |
| Avg. Estimate | 22.45B | 22.04B | 88.78B | 91.28B |
| Low Estimate | 22.19B | 21.7B | 88.49B | 90.29B |
| High Estimate | 22.75B | 22.43B | 89.29B | 91.86B |
| Year Ago Sales | 21.39B | 21.38B | 85.16B | 88.78B |
| Sales Growth (year/est) | 4.95% | 3.06% | 4.26% | 2.82% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| JNJD.XC | -- | -- | -- | -- |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 12/11/2024 |
| Initiated | Wolfe Research: Outperform | 11/15/2024 |
| Maintains | Guggenheim: Neutral to Neutral | 11/6/2024 |
| Maintains | Citigroup: Buy to Buy | 10/16/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 10/16/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 10/16/2024 |